Allergen immunotherapy for birch pollen-allergic patients: recent advances. 2016

Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
Stallergenes Greer, Research Department, 6 rue Alexis de Tocqueville, 92183 Antony Cedex, France.

As of today, allergen immunotherapy is performed with aqueous natural allergen extracts. Recombinant allergen vaccines are not yet commercially available, although they could provide patients with well-defined and highly consistent drug substances. As Bet v 1 is the major allergen involved in birch pollen allergy, with more than 95% of patients sensitized to this allergen, pharmaceutical-grade recombinant Bet v 1-based vaccines were produced and clinically tested. Herein, we compare the clinical results and modes of action of treatments based on either a birch pollen extract or recombinant Bet v 1 expressed as hypoallergenic or natural-like molecules. We also discuss the future of allergen immunotherapy with improved drugs intended for birch pollen-allergic patients suffering from rhinoconjunctivitis.

UI MeSH Term Description Entries
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011058 Pollen The fertilizing element of plants that contains the male GAMETOPHYTES. Male Gametes, Plant,Male Gametophytes,Microspores, Plant,Plant Microspores,Pollen Grains,Gamete, Plant Male,Gametes, Plant Male,Gametophyte, Male,Gametophytes, Male,Grain, Pollen,Grains, Pollen,Male Gamete, Plant,Male Gametophyte,Microspore, Plant,Plant Male Gamete,Plant Male Gametes,Plant Microspore,Pollen Grain
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003233 Conjunctivitis, Allergic Conjunctivitis due to hypersensitivity to various allergens. Allergic Conjunctivitis,Conjunctivitis, Atopic,Conjunctivitis, Giant Papillary,Conjunctivitis, Vernal,Keratoconjunctivitis, Vernal,Allergic Conjunctivitides,Atopic Conjunctivitides,Atopic Conjunctivitis,Conjunctivitides, Allergic,Conjunctivitides, Atopic,Conjunctivitides, Giant Papillary,Conjunctivitides, Vernal,Giant Papillary Conjunctivitides,Giant Papillary Conjunctivitis,Keratoconjunctivitides, Vernal,Papillary Conjunctivitides, Giant,Papillary Conjunctivitis, Giant,Vernal Conjunctivitides,Vernal Conjunctivitis,Vernal Keratoconjunctivitides,Vernal Keratoconjunctivitis
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D006255 Rhinitis, Allergic, Seasonal Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS. Hay Fever,Pollen Allergy,Pollinosis,Seasonal Allergic Rhinitis,Hayfever,Allergic Rhinitides, Seasonal,Allergic Rhinitis, Seasonal,Allergies, Pollen,Allergy, Pollen,Fever, Hay,Pollen Allergies,Pollinoses,Rhinitides, Seasonal Allergic,Rhinitis, Seasonal Allergic,Seasonal Allergic Rhinitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D052179 Antigens, Plant Substances found in PLANTS that have antigenic activity. Plant Antigen,Plant Antigens,Antigen, Plant

Related Publications

Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
May 2010, Current opinion in investigational drugs (London, England : 2000),
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
June 2020, Journal of the European Academy of Dermatology and Venereology : JEADV,
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
March 2019, Allergy,
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
December 2025, Allergy,
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
September 2000, Allergy,
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
March 2019, The Journal of allergy and clinical immunology,
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
January 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
September 1994, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
December 2023, Clinical and experimental pediatrics,
Philippe Moingeon, and Véronique Bordas-Le Floch, and Sabi Airouche, and Véronique Baron-Bodo, and Emmanuel Nony, and Laurent Mascarell
January 2021, International archives of allergy and immunology,
Copied contents to your clipboard!